PREGNANCY TESTS - A REVIEW

被引：109

作者：

CHARD, T

机构：

[1] Department of Reproductive Physiology, and Obstetrics and Gynaecology, St Bartholomew's Hospital Medical College, London Hospital Medical College, London

来源：

HUMAN REPRODUCTION | 1992年 / 7卷 / 05期

关键词：

HCG; PREGNANCY TESTS; ELISA;

D O I：

10.1093/oxfordjournals.humrep.a137722

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Pregnancy tests are widely used both by the public and by healthcare professionals. All tests depend on the measurement of human chorionic gonadotrophin (HCG) in urine. Other pregnancy-specific materials have been proposed as pregnancy tests but none can better the sensitivity and convenience offered by immunoassay of HCG. Ultrasound detection is also not as sensitive as HCG measurement. The current generation of tests is based on monoclonal antibodies to the beta-subunit of HCG; these virtually eliminate the possibility of cross-reaction with pituitary luteinizing hormone (LH) and it is this feature which permits the high sensitivity. However, it is important to recognize that the 'beta-subunit' antibody reacts with both intact HCG, which is the major component in pregnancy serum, and with fragments of the beta-subunit (beta-core), which are the major form in urine. Both the blood and urine of non-pregnant subjects contain small amounts of HCG. HCG from the implanting blastocyst first appears in maternal blood around 6-8 days following fertilization; the levels rise rapidly to reach a peak at 7-10 weeks. With most current pregnancy test kits (sensitivity 25 units per litre) urine may reveal positive results 3-4 days after implantation; by 7 days (the time of the expected period) 98% will be positive. A negative result 1 week after the missed period virtually guarantees that the woman is not pregnant. With the present generation of test kits, false positive results due to interfering materials are extremely unlikely. Pregnancy tests have now reached a level of sensitivity and specificity which is unlikely to be surpassed either by better tests or alternative technology.

引用

页码：701 / 710

页数：10

共 89 条

[11] Birken S., Canfield R., Agosto G., Lewis J., Preparation and characterization of an improved beta COOH-terminal immunogen for generation of specific and sensitive antisera to human chorionic gonadotropin, Endocrinology, 110, pp. 1555-1563, (1982)
[12] Birken S., Armstrong E.G., Kolks M., Cole L.A., Agosto G.M., Krichevsky A., Vaitukaitis J.L., Canfield R.E., Structure of human chorionic gonadotropin beta-subunit fragments from pregnancy urine, Endocrinology, 123, pp. 572-583, (1988)
[13] Body J.J., Muquardt C., Borkowski A., The human chorionic gonadotropin-like substance in the plasma of normal nonpregnant subjects is not modulated by the gonadotropin-releasing hormone, J. Clin. Endocrinol. Metab, 52, pp. 1249-1252, (1981)
[14] Bohn H., Kraus W., Winckler W., New soluble placental tissue proteins: Their isolation, characterization, localization and quantification, Immunology of Human Placental Proteins, pp. 67-81, (1982)
[15] Borkowski A., Puttaert V., Gyling M., Murquardt C., Body J.J., Human chorionic gonadotropin-like substances in plasma of normal nonpregnant subjects and women with breast cancer, J. Clin. Endocrinol. Metab, 58, pp. 1171-1178, (1984)
[16] Braunstein G.D., Rasor J., Adler D., Danzer H., Wade M.E., Serum human chorionic gonadotropin levels throughout normal pregnancy, Am, J. Obstet. Gynecol, 126, pp. 678-681, (1976)
[17] Cacciatore S., Titinen A., Stenman U.H., Ylostalo P., Normal early pregnancy: Serum hCG levels and vaginal ultrasonography findings, Br, J. Obstet. Gynaecoi, 97, pp. 899-903, (1990)
[18] Canfield R.E., O'Connor J.F., Biological markers on human pregnancy, Biomed. Environ. Sci, 4, pp. 56-68, (1991)
[19] Chard T., Frequency of implantation and early pregnancy loss in natural cycles, Bailliere's Clin. Obstet. Gynaecoi, 5, pp. 179-189, (1991)
[20] Chard T., Grudzinskas J.G., Early pregnancy factor, Biol. Res. Preg, 8, pp. 53-56, (1987)

← 1 2 3 4 5 6 7 8 9 →